| Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients M Díaz-Llopis, D Salom, C Garcia-de-Vicuña, M Cordero-Coma, G Ortega, ... Ophthalmology 119 (8), 1575-1581, 2012 | 288 | 2012 |
| Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ... Ophthalmology 125 (5), 757-773, 2018 | 269 | 2018 |
| Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review T Yilmaz, CD Weaver, MJ Gallagher, M Cordero-Coma, ... Ophthalmology 116 (5), 902-913, 2009 | 199 | 2009 |
| Intravitreal bevacizumab for treatment of uveitic macular edema MC Coma, L Sobrin, S Onal, W Christen, CS Foster Ophthalmology 114 (8), 1574-1579. e1, 2007 | 186 | 2007 |
| Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients V Calvo-Río, R Blanco, E Beltrán, J Sánchez-Bursón, M Mesquida, ... Rheumatology 53 (12), 2223-2231, 2014 | 156 | 2014 |
| A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy JJW Kuiper, J Van Setten, S Ripke, R Van ‘T Slot, F Mulder, T Missotten, ... Human molecular genetics 23 (22), 6081-6087, 2014 | 141 | 2014 |
| Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study B Atienza-Mateo, V Calvo-Río, E Beltran, L Martínez-Costa, ... Rheumatology 57 (5), 856-864, 2018 | 136 | 2018 |
| Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study A Riemens, J Bromberg, V Touitou, B Sobolewska, T Missotten, ... JAMA ophthalmology 133 (2), 191-197, 2015 | 136 | 2015 |
| Anti–tumor necrosis factor-α therapy in uveitis M Cordero-Coma, L Sobrin Survey of ophthalmology 60 (6), 575-589, 2015 | 134 | 2015 |
| Anti-IL6-receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients N Vegas-Revenga, V Calvo-Río, M Mesquida, A Adán, MV Hernández, ... American Journal of Ophthalmology 200, 85-94, 2019 | 124 | 2019 |
| Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients V Calvo-Río, R Blanco, M Santos-Gómez, E Rubio-Romero, ... Seminars in arthritis and rheumatism 46 (1), 95-101, 2016 | 112 | 2016 |
| Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients L Riancho-Zarrabeitia, V Calvo-Río, R Blanco, M Mesquida, AM Adan, ... Seminars in arthritis and rheumatism 45 (3), 361-368, 2015 | 104 | 2015 |
| Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease: national multicenter study of 177 cases B Atienza‐Mateo, JL Martín‐Varillas, V Calvo‐Río, R Demetrio‐Pablo, ... Arthritis & Rheumatology 71 (12), 2081-2089, 2019 | 100 | 2019 |
| Golimumab for uveitis M Cordero-Coma, D Salom, M Díaz-Llopis, MJ López-Prats, S Calleja Ophthalmology 118 (9), 1892. e3-1892. e4, 2011 | 95 | 2011 |
| Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis M Cordero-Coma, T Yilmaz, S Onal Ocular immunology and inflammation 21 (1), 19-27, 2013 | 90 | 2013 |
| Successful optimization of adalimumab therapy in refractory uveitis due to Behçet's disease JL Martín-Varillas, V Calvo-Río, E Beltrán, J Sánchez-Bursón, ... Ophthalmology 125 (9), 1444-1451, 2018 | 89 | 2018 |
| The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet’s disease: results of a multicentre open-label study M Santos-Gómez, V Calvo-Río, R Blanco, E Beltrán, M Mesquida, A Adán, ... Clin Exp Rheumatol 34 (6 Suppl 102), S34-S40, 2016 | 86 | 2016 |
| Description and prevalence of spondyloarthritis in patients with anterior uveitis: the SENTINEL Interdisciplinary Collaborative Project X Juanola, EL Santamaría, M Cordero-Coma, SENTINEL Working Group Ophthalmology 123 (8), 1632-1636, 2016 | 81 | 2016 |
| Golimumab as rescue therapy for refractory immune‐mediated uveitis: A three‐center experience M Cordero-Coma, V Calvo-Río, A Adán, R Blanco, C Álvarez-Castro, ... Mediators of Inflammation 2014 (1), 717598, 2014 | 81 | 2014 |
| Systemic immunomodulatory therapy in severe dry eye secondary to inflammation M Cordero-Coma, F Anzaar, L Sobrin, CS Foster Ocular Immunology and Inflammation 15 (2), 99-104, 2007 | 76 | 2007 |
